Mark C. Schiller - 02 Jul 2024 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role: Chief Legal Officer
Signature: /s/ Marc Belsky, Attorney-in-Fact
Issuer symbol: KZR
Transactions as of: 02 Jul 2024
Net transactions value: -$3,879
Form type: 4
Filing time: 26 Jul 2024, 17:41:02 UTC
Previous filing: 17 Jan 2024
Next filing: 13 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KZR	Common Stock	Sale	$3,879	-6,688	-17%	$0.5800	33,007	02 Jul 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Content

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.